Immix Biopharma, Inc. (IMMX): Total Assets
$104.84M
As of 2025-12-31
$239.11M
As of 2026-06-30
+91.6%
3-year compound annual growth
n/m
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $104.84M | +356.9% | 2026-03-27, Balance as of period end |
| 2024-12-31 | $22.95M | +15.2% | 2026-03-27, Balance as of period end |
| 2023-12-31 | $19.93M | +33.7% | 2025-03-25, Balance as of period end |
| 2022-12-31 | $14.91M | -18.1% | 2024-03-29, Balance as of period end |
| 2021-12-31 | $18.19M | n/m | 2023-03-27, Balance as of period end |
| 2020-12-31 | $539.6K | n/a | 2022-03-28, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Immix Biopharma, Inc. (IMMX) | 2025-12-31 | $104.84M | +356.9% |
| Aytu Biopharma, Inc (AYTU) | 2026-06-30 | $105.01M | -15.4% |
| Tenax Therapeutics, Inc. (TENX) | 2025-12-31 | $104.23M | +7.8% |
| Celularity Inc (CELU) | 2025-12-31 | $107.33M | -19.1% |
| Karyopharm Therapeutics Inc. (KPTI) | 2025-12-31 | $108.42M | -34.1% |
| Citius Oncology, Inc. (CTOR) | 2025-09-30 | $100.94M | +19.6% |
| iBio, Inc. (IBIO) | 2026-06-30 | $99.11M | +327.5% |
| Minerva Neurosciences, Inc. (NERV) | 2025-12-31 | $97.97M | +163.8% |
| Rezolute, Inc. (RZLT) | 2026-06-30 | $112.85M | -35.7% |
Compare IMMX, AYTU, TENX, CELU side by side · Screen every company in Pharmaceutical Preparations ↗